TriMas Co. (NASDAQ:TRS) Shares Acquired by Barclays PLC

Barclays PLC boosted its stake in shares of TriMas Co. (NASDAQ:TRS - Free Report) by 89.2% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 21,275 shares of the industrial products company's stock after purchasing an additional 10,028 shares during the quarter. Barclays PLC owned approximately 0.05% of TriMas worth $592,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Norges Bank bought a new stake in TriMas during the 4th quarter valued at $6,443,000. Renaissance Technologies LLC raised its stake in TriMas by 140.5% during the 2nd quarter. Renaissance Technologies LLC now owns 235,370 shares of the industrial products company's stock valued at $6,517,000 after acquiring an additional 137,500 shares in the last quarter. Royce & Associates LP raised its stake in shares of TriMas by 16.3% in the 1st quarter. Royce & Associates LP now owns 772,801 shares of the industrial products company's stock worth $21,530,000 after buying an additional 108,134 shares in the last quarter. Teacher Retirement System of Texas raised its stake in shares of TriMas by 692.3% in the 4th quarter. Teacher Retirement System of Texas now owns 66,363 shares of the industrial products company's stock worth $1,841,000 after buying an additional 57,987 shares in the last quarter. Finally, Vanguard Group Inc. raised its stake in shares of TriMas by 1.1% in the 1st quarter. Vanguard Group Inc. now owns 4,080,071 shares of the industrial products company's stock worth $130,930,000 after buying an additional 44,136 shares in the last quarter. Institutional investors and hedge funds own 99.86% of the company's stock.

Shares of NASDAQ TRS opened at $25.68 on Friday. The company has a quick ratio of 1.50, a current ratio of 2.70 and a debt-to-equity ratio of 0.63. The stock has a market capitalization of $1.06 billion, a price-to-earnings ratio of 22.33 and a beta of 0.72. The stock's fifty day simple moving average is $26.67 and its 200 day simple moving average is $27.24. TriMas Co. has a 52-week low of $21.41 and a 52-week high of $31.89.

TriMas (NASDAQ:TRS - Get Free Report) last issued its earnings results on Thursday, July 27th. The industrial products company reported $0.50 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.50. The business had revenue of $233.19 million for the quarter, compared to analysts' expectations of $255.81 million. TriMas had a return on equity of 9.71% and a net margin of 5.52%. The company's quarterly revenue was down 1.9% on a year-over-year basis. During the same period in the previous year, the firm posted $0.60 EPS. As a group, sell-side analysts forecast that TriMas Co. will post 1.91 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 10th. Stockholders of record on Thursday, August 3rd were issued a dividend of $0.04 per share. The ex-dividend date of this dividend was Wednesday, August 2nd. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.62%. TriMas's dividend payout ratio is 13.91%.

In other news, CAO Paul Swart sold 5,500 shares of TriMas stock in a transaction on Friday, July 28th. The stock was sold at an average price of $27.41, for a total transaction of $150,755.00. Following the transaction, the chief accounting officer now owns 26,749 shares in the company, valued at $733,190.09. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, CFO Scott A. Mell sold 1,200 shares of TriMas stock in a transaction on Thursday, August 3rd. The stock was sold at an average price of $25.80, for a total transaction of $30,960.00. Following the transaction, the chief financial officer now owns 25,664 shares in the company, valued at $662,131.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Paul Swart sold 5,500 shares of the business's stock in a transaction dated Friday, July 28th. The shares were sold at an average price of $27.41, for a total value of $150,755.00. Following the completion of the transaction, the chief accounting officer now owns 26,749 shares in the company, valued at approximately $733,190.09. The disclosure for this sale can be found here. 1.10% of the stock is currently owned by corporate insiders.

A number of analysts have recently commented on TRS shares. BWS Financial started coverage on TriMas in a research note on Monday, May 22nd. They issued a "buy" rating and a $40.00 price objective on the stock. StockNews.com started coverage on TriMas in a research note on Thursday, August 17th. They issued a "hold" rating on the stock. Finally, TheStreet downgraded TriMas from a "b" rating to a "c" rating in a research note on Monday, May 1st.

Check Out Our Latest Stock Analysis on TRS

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. It operates through three segments: Packaging, Aerospace, and Specialty Products. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

Want to see what other hedge funds are holding TRS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TriMas Co. (NASDAQ:TRS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Before you consider TriMas, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.

While TriMas currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.